Computer system validation is our bread and butter. 🥐

In pharma and biotech, digital systems rarely stay the same after they go live. Workflows change, users increase, integrations are added, suppliers release updates, and the system becomes part of a larger operational environment. The real challenge is that oversight does not always evolve at the same pace. A system may still be validated, documented,

SaaS and cloud validation is different because the regulated company no longer controls the full technical stack, but it still owns intended use, oversight, data integrity, access, and compliance. That is where many teams misunderstand the real validation challenge. When a system is vendor-hosted, the validation work does not go away. It shifts. Instead of

For a growing biotech company, implementing the first major digital system is an important milestone. Paper records, spreadsheets, shared drives, and disconnected tools that worked during early growth may no longer support increasing operational complexity, regulatory expectations, or future scale. The natural response is often to start evaluating software. But selecting an eQMS, LIMS, LMS,

How Assurea validated a U.S. deployment of Veeva Vault Quality and established a reusable validation framework for future global site rollouts. Project Overview When a global Contract Development and Manufacturing Organization (CDMO) selected Veeva Vault Quality to standardize its quality management processes, the first deployment was planned for a U.S. manufacturing site located on the

Many life sciences organizations commonly ask this question when implementing a SaaS platform: “If the vendor already validated the system, what do we still need to do?” The answer is straightforward. The vendor is responsible for the platform it develops, operates, and maintains. The regulated company remains responsible for how that platform is configured, governed,

In today’s digital biotech environment, labs and manufacturing sites rely on a complex network of interconnected systems: LIMS, QMS, MES, ERP, CDS, eBMRs, data historians, and analytics platforms. While each system may be validated independently, the movement of data between them is where the highest risk now lives. Regulators increasingly expect organizations to demonstrate end-to-end

Background: A Late-Stage Biopharma Preparing for EU Commercialization A mid-sized U.S.-based biopharmaceutical company was preparing to commercialize its first biologic product in the European Union. As part of its global expansion strategy, the company initiated a technology transfer from its U.S. clinical manufacturing facility to a commercial EU site (located in Ireland). While the company

Client: A Biotech CompanyIndustry: Life Sciences / Pharmaceutical ManufacturingSize: 150–200 employeesEngagement Type: Full-service contract staffing partnershipPartner: Assurea Background A rapidly growing biotech company specializing in cell and gene therapy recently secured Series C funding to expand its manufacturing capacity. The organization planned to establish a new biomanufacturing site in New Jersey, aimed at scaling production

The FDA has finalized its Computer Software Assurance for Production and Quality System Software guidance — a long-awaited update that signals the end of “business as usual” for software validation in regulated industries. For decades, Computerized System Validation (CSV) has been the framework life sciences companies relied on. While it provided structure, CSV often created

Background A mid-sized U.S.-based medical device manufacturer was preparing to initiate a clinical trial for a new Class II device. The company needed additional Clinical Research Associate (CRA) support to oversee trial sites, ensure protocol compliance, and meet regulatory expectations. With limited internal bandwidth and a fast-approaching study start date, the client turned to Assurea’s

Client: Mid-sized biotech company developing novel biologics.Industry: Biotechnology / Life SciencesPositions: 2 QA Specialists and 3 Validation Engineers Background A biotech company was advancing a promising therapeutic candidate through clinical studies toward commercialization. To meet FDA submission timelines, validation of their GMP manufacturing and QC lab equipment and systems had to be completed within six

As part of preparing for commercial readiness, a Phase 3 biotech client faced a pivotal challenge: expanding into the European Union while meeting critical regulatory filing and inspection requirements. Their internal regulatory team was well-versed in U.S. requirements but lacked specific expertise in EU Module 3 expectations, centralized procedures, and regional submission strategy. The challenge:

Whether you’re running a biologics manufacturing plant, managing clinical trial data, or operating a quality management system, your computerized systems play a critical role in ensuring product quality and patient safety. But systems age, users change, processes evolve—and what worked flawlessly two years ago might be a compliance risk today. That’s where periodic reviews come

As biotech companies scale from clinical to commercial manufacturing, expansion of GMP facilities brings both exciting growth opportunities and complex regulatory challenges. One area that demands foresight is Computer System Validation (CSV) — the process of ensuring that software systems used in GMP environments are functioning as intended and in compliance with regulations such as

Setting up a GMP-compliant manufacturing site is one of the most critical steps for a biotech company transitioning into clinical or commercial production. In today’s digital landscape, implementing robust Computer System Validation (CSV) practices from the outset is essential—not only to meet regulatory expectations but to ensure seamless, reliable, and compliant operations across your production

As biotech companies move into clinical trials or commercial readiness, their Quality Control (QC) labs must scale quickly to support expanding operations. But scaling a QC lab isn’t just about acquiring more instruments or running more tests. It’s about validating smarter. Computer System Validation (CSV) becomes increasingly important—and complex—as companies prepare for INDs, BLAs, or

Launching a biotech company is an exciting journey, especially when it’s time to build your first GMP-compliant Quality Control (QC) lab. Amid the rush to select instruments, hire scientists, and finalize test methods, one foundational piece often gets overlooked—Computer System Validation (CSV). Whether you’re preparing for your first IND or simply trying to get your

Bringing an asset management system into a biotech environment isn’t just about picking the right tool—it’s about ensuring that tool is validated, compliant, and meets both regulatory and business needs. Whether you’re handling equipment calibrations, managing work orders, or ensuring traceable maintenance histories, Computer System Validation (CSV) is a critical step. Here’s what you need

Digitizing manufacturing with an MES is a big step, especially in regulated spaces like pharma and biotech. But alongside innovation comes responsibility—especially when it comes to compliance. Since MES sits at the heart of production, enforcing process controls and managing real-time data, it’s essential to validate the system to ensure it performs reliably, consistently, and

As biotech companies scale, user-friendly software systems—like EQMS, LIMS, or MES— can help standardize operations, ensure data integrity, and support regulatory compliance. But before signing a contract, it’s critical to better understand what the system can do and how it’s built, maintained, and supported behind the scenes. So, how do you dive into what really